Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
Condition: SARS-CoV-2 Infection Intervention: Biological: B/HPIV3/S-6P Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Research | SARS | Study | Vaccines